gallic acid has been researched along with Diabetic Nephropathies in 6 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gallic acid is a type of phenolic acid that has been shown to be a potential drug candidate to treat diabetic kidney disease, an important complication of diabetes." | 1.91 | Gallic acid improves the metformin effects on diabetic kidney disease in mice. ( Hong, Y; Sun, W; Wang, J; Xu, X; Zhang, K; Zhang, L, 2023) |
| "Gallic acid treatment significantly lowered plasma levels of the creatinine and blood urea nitrogen and elevated the levels of the protein and albumin." | 1.48 | Gallic acid attenuates type I diabetic nephropathy in rats. ( Garud, MS; Kulkarni, YA, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, Y | 1 |
| Wang, J | 1 |
| Sun, W | 1 |
| Zhang, L | 1 |
| Xu, X | 1 |
| Zhang, K | 1 |
| Rashedinia, M | 1 |
| Khoshnoud, MJ | 1 |
| Fahlyan, BK | 1 |
| Hashemi, SS | 1 |
| Alimohammadi, M | 1 |
| Sabahi, Z | 1 |
| Mojadami, S | 1 |
| Ahangarpour, A | 1 |
| Mard, SA | 1 |
| Khorsandi, L | 1 |
| Garud, MS | 1 |
| Kulkarni, YA | 1 |
| Cai, S | 1 |
| Zhong, Y | 1 |
| Li, Y | 1 |
| Huang, J | 1 |
| Zhang, J | 1 |
| Luo, G | 1 |
| Liu, Z | 1 |
| Ahad, A | 1 |
| Ahsan, H | 1 |
| Mujeeb, M | 1 |
| Siddiqui, WA | 1 |
6 other studies available for gallic acid and Diabetic Nephropathies
| Article | Year |
|---|---|
Gallic acid improves the metformin effects on diabetic kidney disease in mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gallic | 2023 |
Syringic Acid: A Potential Natural Compound for the Management of Renal Oxidative Stress and Mitochondrial Biogenesis in Diabetic Rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gallic Acid; Humans; | 2021 |
Diabetic nephropathy induced by methylglyoxal: gallic acid regulates kidney microRNAs and glyoxalase1-Nrf2 in male mice.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Fibrosis; Gallic Acid; Kidney; Male; Mice; Micro | 2023 |
Gallic acid attenuates type I diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetes Me | 2018 |
Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3"Me in the alloxan-induced diabetic kidney.
Topics: Analysis of Variance; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Di | 2013 |
Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephr | 2015 |